Redefining RNA Manufacturing Through Innovation in Biocatalysis
The Increasing Importance of Manufacturability in API Development
Digital Quality Management Systems as Strategic Enablers of Patient-Centric Manufacturing Excellence
Navigating the U.S. CDMO Industry
Single Use Technologies (SUT) in Pharmaceutical Manufacturing
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Analytical Testing in Pharma and Biotech: Applications, Challenges, and Future Perspectives
Analytical testing is a fundamental component of the pharmaceutical and biotechnology industries and serves as the scientific basis for assessing product quality throughout the product lifecycle It provides reliable data to demonstrate that raw materials
-
Techno Trends
University Researchers Develop CAR T Therapy Candidate for Solid Tumour Treatment
Researchers from the University of Calgary and McMaster University have developed a novel CAR T cell therapy approach targeting treatmentresistant solid tumours
-
Projects
BeOne Medicines Invests US$300 Million to Expand New Jersey Manufacturing Campus
BeOne Medicines has announced a US million expansion of its Princeton West Innovation Campus in Hopewell New Jersey strengthening its US manufacturing and research capabilities
-
Research Insights
Drug Costs in Federally Sponsored Cancer Clinical Trials
Importance Federally sponsored cancer clinical trials FSCCTs address research questions often overlooked by industry eg pharmaceutical or biotechnology companies such as treatment combinations
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Vectorizing Hope: The Art and Science of Gene Therapy Vector Manufacturing
Kate Williamson
Gene therapy vector manufacturing is a dynamic field merging art and science to address genetic disorders. It involves precise vector design, production, and quality control. Challenges like safety an...
-
2
Advances and Innovations in Cell and Gene Therapy
Kate Williamson
Modern cell and gene therapy continues to evolve because of three key developments including CRISPR gene editing and mRNA technology within gene therapy as well as CAR-T cell therapy used for autoimmu...
-
3
Key Challenges in Drug Manufacturing and How to Overcome Them
Kate Williamson
Some of the issues intrinsic to drug manufacturing include the capability to maintain quality, regulatory requirements, cost, supply chain issues, expansion, information technology interface, and the...
-
4
What Challenges and Opportunities Define Modern CNS Drug Development?
Kate Williamson
The landscape of modern CNS drug development is marked by challenges including CNS complexity, BBB limitations, disease heterogeneity, biomarker scarcity, safety concerns, limited treatments, regulato...
-
5
Pharma Smart Manufacturing: Leveraging IoT and Digital Twins for Next-Gen Production
Kate Williamson
Pharma smart manufacturing is a combination of IoT, digital twin, and high-level automation in order to revolutionize the pharmaceutical production. Smart manufacturing in pharma allows streamlining o...
press releasesRead more...
Genentech Announces Manufacturing Expansion in Hillsboro, Oregon
Genentech a member of the Roche Group SIX RO ROP OTCQX RHHBY today announced plans to invest approximately million in a new device fillfinish manufacturing facility at its acre campus
Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma
Nuvation Bio Inc NYSE NUVB a global oncology company focused on tackling some of the toughest challenges in cancer treatment today announced that the US Food and Drug Administration FDA
Implantica receives FDA approval for RefluxStop® – Opening the U.S. market
Implantica AG publ a medtech company at the forefront of introducing advanced technology into the body announced today that the US Food and Drug Administration FDA has granted Premarket Approval
Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva (FOP)
Regeneron Pharmaceuticals Inc NASDAQ REGN today announced the US Food and Drug Administration FDA has granted approval for Pasatru garetosmabgrts to reduce formation of new heterotopic ossification
Events Read more...
19 - 21
Aug 2026ISPE Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
09 - 10
Sep 2026iPSC Drug Development Summit
Hyatt Regency Boston Harbour,...
LATEST NEWSRead more...
Chai Discovery Collaborates with Bristol Myers Squibb on AI-Driven Antibody Discovery
Chai Discovery an AI company developing computeraided design tools for molecules has announced a collaboration with Bristol Myers Squibb to support the discovery of therapeutic antibodies using artificial intelligence
Charles River Laboratories and Medigen Collaborate on Next-Generation Enterovirus Vaccine Development
Charles River Laboratories International and Medigen Vaccine Biologics Corp MVC have entered into a collaboration to support the development of MVCs nextgeneration multivalent enterovirus vaccine
Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop taRNA Vaccines for Infectious Diseases
Amplitude Therapeutics a biotechnology company developing transamplifying RNA taRNA medicines and vaccines has entered into a strategic research collaboration and licensing agreement with Eli Lilly and Company to discover and develop taRNA vaccine candidates for infectious diseases
IDEAYA Biosciences and Genentech Collaborate on Targeted Treatment for Pancreatic Cancer
IDEAYA Biosciences Inc NASDAQ IDYA has entered into a clinical collaboration with Genentech a member of the Roche Group to evaluate IDE in combination with GDC RG
Pliant Therapeutics receives FDA Fast Track designation for PLN-101095 in combination with pembrolizumab
Pliant Therapeutics has received Fast Track designation from the US Food and Drug Administration FDA for PLN in combination with pembrolizumab for the potential treatment of solid tumours that are resistant to immune checkpoint inhibitors ICIs
GenBio AI builds virtual world model of the human cell
Pliant Therapeutics has received Fast Track designation from the US Food and Drug Administration FDA for PLN in combination with pembrolizumab for the potential treatment of solid tumours that are resistant to immune checkpoint inhibitors ICIs
